Genedx Holdings Corp | Mid-cap | Healthcare
$126.36
2.83%
| Genedx Holdings Stock Comparison:
Genedx Holdings vs Thermo FisherGenedx Holdings vs DanaherGenedx Holdings vs Exact SciencesGenedx Holdings vs Charles RiverGenedx Holdings vs Guardant HealthGenedx Holdings vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 102.7M
Gross Profit 70.9M 69.04%
Operating Income 9.0M 8.73%
Net Income 10.8M 10.53%
EPS (Diluted) $0.36

Balance Sheet Metrics

Total Assets 446.4M
Total Liabilities 189.0M
Shareholders Equity 257.4M
Debt to Equity 0.73

Cash Flow Metrics

Operating Cash Flow -1.7M
Free Cash Flow 4.1M

Revenue & Profitability Trend

Genedx Holdings Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i305.4M202.6M234.7M212.2M179.3M
Cost of Goods Sold i111.1M112.6M261.4M228.8M175.3M
Gross Profit i194.4M90.0M-26.8M-16.6M4.0M
Gross Margin % i63.6%44.4%-11.4%-7.8%2.2%
Operating Expenses
Research & Development i45.7M58.3M86.2M105.2M72.7M
Selling, General & Administrative i168.5M194.7M338.2M318.7M163.9M
Other Operating Expenses i3.4M7.2M6.3M5.7M9.4M
Total Operating Expenses i217.6M260.2M430.8M429.5M246.0M
Operating Income i-23.2M-170.2M-457.5M-446.1M-242.0M
Operating Margin % i-7.6%-84.0%-194.9%-210.3%-134.9%
Non-Operating Items
Interest Income i--2.5M79.0K506.0K
Interest Expense i--3.2M2.8M2.5M
Other Non-Operating Income-26.4M-7.6M-139.9M203.5M2.6M
Pre-tax Income i-52.6M-176.7M-598.0M-245.4M-241.3M
Income Tax i-343.0K-926.0K-49.1M00
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-52.3M-175.8M-549.0M-245.4M-241.3M
Net Margin % i-17.1%-86.8%-233.9%-115.6%-134.6%
Key Metrics
EBITDA i12.1M-127.2M-258.3M-419.1M-227.1M
EPS (Basic) i$-1.94$-7.23$-53.79$-74.91$-33.16
EPS (Diluted) i$-1.94$-7.23$-53.79$-74.91$-33.16
Basic Shares Outstanding i26891213243119891023695932750737278497
Diluted Shares Outstanding i26891213243119891023695932750737278497

Income Statement Trend

Genedx Holdings Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i85.2M99.7M123.9M400.6M108.1M
Short-term Investments i56.0M30.5M0--
Accounts Receivable i37.4M32.4M42.6M26.5M32.0M
Inventory i10.6M8.8M13.7M33.5M25.0M
Other Current Assets1.1M2.0M31.7M23.0M8.7M
Total Current Assets i198.0M182.3M212.6M483.5M174.1M
Non-Current Assets
Property, Plant & Equipment i47.2M45.0M95.4M49.9M43.6M
Goodwill i158.6M172.6M186.6M0-
Intangible Assets i158.6M172.6M186.6M--
Long-term Investments-----
Other Non-Current Assets4.3M4.4M7.4M7.8M14.4M
Total Non-Current Assets i221.4M236.4M278.3M70.5M77.5M
Total Assets i419.4M418.8M490.9M554.1M251.6M
Liabilities
Current Liabilities
Accounts Payable i8.0M10.2M46.0M44.7M26.7M
Short-term Debt i3.3M3.6M10.9M3.4M5.3M
Current Portion of Long-term Debt-----
Other Current Liabilities2.8M2.0M24.7M8.9M4.5M
Total Current Liabilities i54.8M58.8M144.3M101.3M73.4M
Non-Current Liabilities
Long-term Debt i112.8M115.6M66.3M11.0M39.7M
Deferred Tax Liabilities i965.0K1.6M2.7M0-
Other Non-Current Liabilities--1.6M32.2M2.1M
Total Non-Current Liabilities i119.3M131.9M92.9M64.7M508.3M
Total Liabilities i174.1M190.7M237.2M166.0M581.7M
Equity
Common Stock i2.0K2.0K1.0K24.0K0
Retained Earnings i-1.4B-1.3B-1.1B-575.4M-330.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i245.2M228.0M253.7M388.1M-330.1M
Key Metrics
Total Debt i116.2M119.3M77.1M14.4M45.0M
Working Capital i143.2M123.5M68.3M382.3M100.7M

Balance Sheet Composition

Genedx Holdings Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-52.3M-175.8M-549.0M-245.4M-241.3M
Depreciation & Amortization i22.0M33.7M59.3M21.8M11.7M
Stock-Based Compensation i9.1M-326.0K42.0M219.4M120.2M
Working Capital Changes i-4.3M8.7M-20.0M-3.6M-3.5M
Operating Cash Flow i-21.6M-141.9M-514.1M-6.1M-110.4M
Investing Activities
Capital Expenditures i-5.5M-5.2M-7.2M-9.4M-24.1M
Acquisitions i--12.1M-127.0M00
Investment Purchases i-66.3M-47.7M0--
Investment Sales i41.7M17.8M0--
Investing Cash Flow i-30.1M-55.4M-134.2M-9.4M-24.1M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i048.5M0015.9M
Debt Repayment i-3.2M-5.6M-3.3M-13.5M-4.2M
Financing Cash Flow i43.3M186.0M392.0M492.5M129.1M
Free Cash Flow i-34.0M-185.9M-333.5M-211.2M-125.1M
Net Change in Cash i-8.4M-11.4M-256.3M476.9M-5.5M

Cash Flow Trend

Genedx Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 1,507.81
Forward P/E 246.17
Price to Book 12.50
Price to Sales 9.56
PEG Ratio -11.21

Profitability Ratios

Profit Margin 0.39%
Operating Margin 8.73%
Return on Equity 0.60%
Return on Assets 1.05%

Financial Health

Current Ratio 2.87
Debt to Equity 41.27
Beta 2.08

Per Share Data

EPS (TTM) $0.08
Book Value per Share $9.65
Revenue per Share $12.99

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
wgs3.5B1,507.8112.500.60%0.39%41.27
Thermo Fisher 184.7B28.253.6613.42%15.24%69.62
Danaher 151.0B44.882.896.68%14.21%35.45
Exact Sciences 8.6B-8.163.49-35.51%-34.19%102.73
Charles River 7.7B681.332.30-1.81%-1.66%82.04
Guardant Health 7.3B-16.54-23.92312.48%-49.93%-4.37

Financial data is updated regularly. All figures are in the company's reporting currency.